Dr. Helen Moore is a mathematician and Principal Scientist at AstraZeneca in the Boston area. She received her PhD in mathematics in 1995 from Stony Brook University. Her original work in differential geometry focused on shapes that minimize volume under certain constraints. Over a period of 11 years in academia, she won two teaching awards and received a National Science Foundation grant for her research. While at Stanford University, she began collaborating with faculty in the medical school, and shifted her use of optimization techniques to apply them to therapies for cancer, HIV, and hepatitis C.
Dr. Moore was the Associate Director of the American Institute of Mathematics in Palo Alto, California for four years. Her first industry position was in the Modeling and Simulation group at Genentech. She later worked at Pharsight/Certara in both the consulting group and as a software and nonlinear mixed-effects modeling instructor. She returned to the east coast in 2014 to join Bristol-Myers Squibb, and moved to AstraZeneca in 2018. She uses mathematics and statistics to model diseases and drug concentrations to optimize drug regimens and improve drug development. She was recently named a Fellow of the Society for Industrial and Applied Mathematics.